✦ LIBER ✦

Long-Term Outcomes With Ambrisentan Monotherapy in Pulmonary Arterial Hypertension

✍ Scribed by Shannon E. Blalock; Susan Matulevicius; Laura C. Mitchell; Sharon Reimold; John Warner; Ronald Peshock; Fernando Torres; Kelly M. Chin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Pulmonary Hemodynamic Effects

✍ James R. Klinger; Ronald J. Oudiz; Rebecca Spence; Darrin Despain; Christopher D 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 399 KB

Long-Term Hepatic Safety of Ambrisentan

✍ Ori Ben-Yehuda; David Pizzuti; Andrea Brown; Marcus Littman; Hunter Gillies; Nor 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 378 KB

Long-term outcomes in pulmonary arterial

✍ T. Thenappan; H. I. Palevsky 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Long-Term Ambrisentan Therapy for the Tr

✍ Ronald J. Oudiz; Nazzareno Galiè; Horst Olschewski; Fernando Torres; Adaani Fros 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 904 KB

Ambrisentan for pulmonary arterial hyper

✍ Michele D'Alto; Emanuele Romeo; Paola Argiento; Anna Correra; Berardo Sarubbi; G 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Clinical review and long-term outcomes i

✍ A. Labbe; G. Labbe 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 42 KB